| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Biophys J, March 2000, p. 1293-1305, Vol. 78, No. 3

Departments of *Pediatrics and
Physiology and
Biophysics, Case Western Reserve University School of Medicine,
Cleveland, Ohio 44106 USA
The R domain of cystic fibrosis transmembrane conductance
regulator (CFTR), when phosphorylated, undergoes conformational change,
and the chloride channel opens. We investigated the contribution of R
domain conformation, apart from the changes induced by phosphorylation, to channel opening, by testing the effect of the peptidyl-prolyl isomerase, cyclophilin A, on the CFTR channel. When it was applied after the channel had been opened by PKA phosphorylation, cyclophilin A
increased the open probability of wild-type CFTR (from
Po = 0.197 ± 0.010 to
Po = 0.436 ± 0.029) by increasing
the number of channel openings, not open time. Three highly conserved
proline residues in the R domain, at positions 740, 750, and 759, were considered as candidate targets for cyclophilin A. Mutations of these
prolines to alanines (P3A mutant) resulted in a channel unresponsive to
cyclophilin A but with pore properties similar to the wild type, under
strict control of PKA and ATP, but with significantly increased open
probability (Po = 0.577 ± 0.090) compared to wild-type CFTR, again due to an increase in the number of
channel openings and not open time. Mutation of each of the proline
residues separately and in pairs demonstrated that all three proline
mutations are required for maximal Po. When
P3A was expressed in 293 HEK cells and tested by SPQ assay, chloride efflux was significantly increased compared to cells transfected with
wild-type CFTR. Thus, treatments favoring the
trans-peptidyl conformation about conserved proline
residues in the R domain of CFTR affect openings of CFTR, above and
beyond the effect of PKA phosphorylation.
Biophys J, March 2000, p. 1293-1305, Vol. 78, No. 3
© 2000 by the Biophysical Society 0006-3495/00/03/1293/13 $2.00
This article has been cited by other articles:
![]() |
Z.-J. Chen, M. Vetter, G.-D. Chang, S. Liu, D. Che, Y. Ding, S. S. Kim, and C.-H. Chang Cyclophilin A Functions as an Endogenous Inhibitor for Membrane-Bound Guanylate Cyclase-A Hypertension, December 1, 2004; 44(6): 963 - 968. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta, J. Xie, J. Ma, and P. B. Davis Intermolecular Interaction Between R Domains of Cystic Fibrosis Transmembrane Conductance Regulator Am. J. Respir. Cell Mol. Biol., February 1, 2004; 30(2): 242 - 248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Cai and D. N. Sheppard Phloxine B Interacts with the Cystic Fibrosis Transmembrane Conductance Regulator at Multiple Sites to Modulate Channel Activity J. Biol. Chem., May 24, 2002; 277(22): 19546 - 19553. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ostedgaard, J. Zabner, D. W. Vermeer, T. Rokhlina, P. H. Karp, A. A. Stecenko, C. Randak, and M. J. Welsh CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo PNAS, February 14, 2002; (2002) 261714599. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Baldursson, L. S. Ostedgaard, T. Rokhlina, J. F. Cotten, and M. J. Welsh Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channels with R Domain Deletions and Translocations Show Phosphorylation-dependent and -independent Activity J. Biol. Chem., January 12, 2001; 276(3): 1904 - 1910. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. S. Ostedgaard, O. Baldursson, and M. J. Welsh Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator Cl- Channel by Its R Domain J. Biol. Chem., March 9, 2001; 276(11): 7689 - 7692. [Full Text] [PDF] |
||||
![]() |
L. S. Ostedgaard, J. Zabner, D. W. Vermeer, T. Rokhlina, P. H. Karp, A. A. Stecenko, C. Randak, and M. J. Welsh CFTR with a partially deleted R domain corrects the cystic fibrosis chloride transport defect in human airway epithelia in vitro and in mouse nasal mucosa in vivo PNAS, March 5, 2002; 99(5): 3093 - 3098. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |